Eesti -
eesti -
Ravimiamet
tramadol lannacher 150mg toimeainet prolongeeritult vabastav tablett
g.l. pharma gmbh - tramadool - toimeainet prolongeeritult vabastav tablett - 150mg 30tk; 150mg 10tk
Eesti -
eesti -
Ravimiamet
tramadol lannacher 200 mg toimeainet prolongeeritult vabastav tablett
g.l. pharma gmbh - tramadool - toimeainet prolongeeritult vabastav tablett - 200mg 30tk
Eesti -
eesti -
Ravimiamet
tramvetol süstelahus
virbac - tramadool - süstelahus - 43,9mg 1ml 1ml 10tk
Eesti -
eesti -
Ravimiamet
propomitor süste-/infusiooniemulsioon
orion corporation - propofool - süste-/infusiooniemulsioon - 10mg 1ml 50ml 1tk; 10mg 1ml 100ml 1tk; 10mg 1ml 20ml 1tk; 10mg 1ml 20ml 5tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - ravimid hingamisteede obstruktiivsete haiguste, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastilised ained - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
Eesti -
eesti -
Ravimiamet
ontipria inhalatsioonipulber kõvakapslis
zentiva k.s. - tiotroopium - inhalatsioonipulber kõvakapslis - 18mcg 90tk; 18mcg 30tk; 18mcg 60tk